CVI Holdings, LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 13 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CVI Holdings, LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$40,478
-17.7%
56,416
-25.3%
0.08%
+53.8%
Q2 2023$49,161
-50.0%
75,528
-53.9%
0.05%
+40.5%
Q1 2023$98,263
+25.9%
163,772
-17.6%
0.04%
+270.0%
Q4 2022$78,054
-69.6%
198,812
-15.0%
0.01%
-50.0%
Q3 2022$257,000
+17.9%
233,930
-4.5%
0.02%
+25.0%
Q2 2022$218,000
-57.8%
244,825
-9.0%
0.02%
-52.9%
Q1 2022$517,000
-22.3%
269,138
-7.8%
0.03%
-22.7%
Q4 2021$665,000
+22.2%
291,832
+58.7%
0.04%
+29.4%
Q3 2021$544,000183,8500.03%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 15,830$36,0000.11%
CVI Holdings, LLC 291,832$665,0000.04%
Sio Capital Management, LLC 49,998$114,0000.03%
Exos Asset Management LLC 27,151$62,0000.03%
Ionic Capital Management LLC 100,389$229,0000.03%
Alpine Global Management, LLC 47,500$108,0000.02%
TUDOR INVESTMENT CORP ET AL 236,549$539,0000.01%
LMR Partners LLP 50,000$363,0000.00%
Diameter Capital Partners LP 23,857$54,0000.00%
Virtu Financial LLC 10,314$24,0000.00%
View complete list of HUMACYTE INC shareholders